Result of General Meeting & Total Voting Rights
Summary by AI BETAClose X
Light Science Technologies Holdings plc
("LSTH", "Light Science", the "Company" or the "Group")
Result of General Meeting
and
Total Voting Rights
Light Science Technologies Holdings plc (AIM: LST), the innovative technology and manufacturing business providing real-world solutions targeting issues including global food security and fire safety, announces that at the General Meeting of the Company held earlier today, all Resolutions were duly passed.
Resolution 1 was passed as an Ordinary Resolution and Resolution 2 was passed as a Special Resolution. Voting on all resolutions at the General Meeting was conducted by poll and the results are as follows:
|
Resolution |
For |
% |
Against |
% |
Vote Total |
Withheld* |
|
Resolution 1 |
211,333,020 |
99.7 |
672,560 |
0.3 |
212,005,580 |
243,081 |
|
Resolution 2 |
210,939,070 |
99.5 |
1,060,791 |
0.5 |
211,999,861 |
248,800 |
Following approval of the Resolutions at the General Meeting, the Company will proceed with completion of the Second Placing, the Third Placing and the Retail Offer, together with the implementation of the Acquisitions, in each case as previously announced. Application has been made for the admission of 593,398,900 new Ordinary Shares to trading on AIM, comprising 150,000,000 EIS/VCT Placing Shares, 383,398,900 Third Placing Shares and 60,000,000 Retail Shares. The Second Admission (in respect of the EIS/VCT Placing Shares) is expected to become effective and dealings commencing at 8.00 a.m. on 13 April 2026, and the Third Admission (in respect of the Third Placing Shares and the Retail Offer Shares) is expected to become effective and dealings commencing at 8.00 a.m. on 14 April 2026.
Of the Second Placing, 30,000,000 EIS/VCT Placing Shares will be issued by way of direct subscription to certain investors, on the same terms and at the same Issue Price as the Second Placing. Settlement of these subscription shares will occur as part of the Second Admission.
Total Voting Rights
Following Admission of the Second Placing Shares, the Third Placing Shares and the Retail Offer Shares, the Company's issued share capital will consist of 993,005,500 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company will be 993,005,500. With effect from Third Admission, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Capitalised terms used but not defined in this announcement have the meanings given to them in the Company's announcement released at 7am on 11 March 2026 in respect of the Fundraising unless the context provides otherwise.
* A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
For additional information please contact:
|
Light Science Technologies Holdings plc Simon Deacon, Chief Executive Officer Jim Snooks, Chief Financial Officer Andrew Hempsall, Chief Operating Officer
|
www.lightsciencetechnologiesholdings.com via Walbrook PR
|
|
Shore Capital (Nominated Adviser and Broker) Stephane Auton / George Payne
|
+44 (0)20 7408 4050 |
|
Walbrook PR Ltd (Media & Investor Relations) Nick Rome / Marcus Ulker |
Tel: +44 (0)20 7933 8780 or lst@walbrookpr.com |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 33 minutes ago Prudential
- 44 minutes ago Vanquis Banking Group 20
- 3 hours ago Frasers Group
- 3 hours ago Cavendish Financial
- 3 hours ago Diaceutics